Cannassure Therapeutics Ltd. announces that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. The company's innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays. Currently, the common methods of use for medical cannabis are by inhalation of smoke or vapor, or sublingual drops, and many patients are reluctant to use cannabis due to these methods.